Elite Pharmaceuticals ELTP
OTC ELTP
$0.24 +0.00 (+0.00%)
As of: Oct 21, 2026 · 11:00 AM EDT

Elite Pharmaceuticals (ELTP) Other Non-Current Liabilities (2011 - 2026)

Updated

Elite Pharmaceuticals (ELTP) posted Other Non-Current Liabilities of $17.25 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 63.5% from $47.31 million a year earlier and down 0.5% from the prior quarter.

Analysis

Elite Pharmaceuticals (ELTP) Other Non-Current Liabilities (2011 - 2026) Analysis & Trends

At the end of FY2026 (ended Mar 31, 2026), Elite Pharmaceuticals' Other Non-Current Liabilities came in at $17.34 million, down 31.2% from FY2025.

  • Annual Other Non-Current Liabilities shows a five-year compound annual growth rate of 49.0% (FY2021 to FY2026).
  • In prior fiscal years, Elite Pharmaceuticals' Other Non-Current Liabilities was $25.2 million in FY2025 (+300.1%), $6.3 million in FY2024, $521,711 in FY2023 (-44.3%) and $936,837 in FY2022 (-60.3%).
  • The fiscal Q1 2027 figure stands as the lowest quarterly Other Non-Current Liabilities since fiscal Q1 2025.
  • On a year-over-year basis, Other Non-Current Liabilities has declined in each of the last three quarters, with growth averaging 222.3% over the last eight quarters.
  • The strongest year-over-year quarter for Other Non-Current Liabilities in the past five years was fiscal Q2 2025, with growth of 586.8%; the weakest was fiscal Q1 2027, with a decline of 63.5%.
  • According to Business Quant data, Other Non-Current Liabilities for the three prior fiscal quarters was $17.34 million (Q4 2026), $27.97 million (Q3 2026) and $39.79 million (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Elite Pharmaceuticals 268.12 Mn 149.80 Mn 13.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 17.25 Mn
Mar 31, 2026 17.34 Mn
Dec 31, 2025 27.97 Mn
Sep 30, 2025 39.79 Mn
Jun 30, 2025 47.31 Mn
Mar 31, 2025 25.20 Mn
Dec 31, 2024 33.57 Mn
Sep 30, 2024 21.84 Mn
Jun 30, 2024 9.08 Mn
Mar 31, 2024 6.30 Mn
Dec 31, 2023 5.60 Mn
Sep 30, 2023 3.18 Mn
Jun 30, 2023 711,078.00
Mar 31, 2023 521,711.00
Dec 31, 2022 375,767.00
Sep 30, 2022 748,661.00
Jun 30, 2022 1.44 Mn
Mar 31, 2022 936,837.00
Dec 31, 2021 877,039.00
Sep 30, 2021 1.37 Mn
API Access

Elite Pharmaceuticals Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ELTP&period=max&api_key=YOUR_API_KEY